This report is not a personal recommendation and does not take into account your personal circumstances or appetite for risk.
This page refreshes automatically every 30 mins. Press F5 to update manually
For a more detailed explanation of Upgrades/Downgrades see Link
Key: (?) = Upgraded, (?) = Downgraded, (-) = Maintained
Aberdeen Asset Management | RBC cuts TP to 480p from 495p, outperform |
Cape | JP Morgan downgrades to neutral from overweight; cuts TP to 299p from 320p |
Carnival | Barclays cuts TP to 2000p from 2340p, Equalweight |
Centrica | JP Morgan downgrades to neutral from overweight; cuts TP to 375p from 390p |
Diploma | Jefferies ups TP to 720p from 690p, Buy |
Entertainment One | N+1 Singer initiates with Buy rating; TP of 258p |
Hilton Food Group | Investec ups TP to 450p from 352p, add |
Keywords Studios | Numis ups to Buy from Hold |
Lamprell | JP Morgan ups to overweight from neutral; ups TP to 175p from 172p |
Liontrust Asset Management | N+1 singer ups TP to 282p from 230p, Buy |
London Mining | Credit Suisse ups TP to 170p from 160p, outperform |
London Mining | Investec ups TP to 130p from 98p, Hold |
Mothercare | N+1 Singer ups to Buy from Hold |
Motivcom | Numis ups TP to 183p, Buy |
Premier Farnell | UBS cuts TP to 225p from 235p, neutral |
Retroscreen Virology Group | Numis downgrades to Hold from add; ups TP by 60p to 350p |
Talktalk Telecom | Barclays ups TP to 320p from 300p, overweight |
Tullow Oil | Barclays ups TP to 1500p from 1490p, overweight |
Source: Reuters News, AlphaTerminal, Dow Jones Newswires |
Source: Bloomberg, Reuters News, AlphaTerminal, Dow Jones Newswires
T111his research is produced by Accendo Markets Limited. Research produced and disseminated by Accendo Markets is classified as non-independent research, and is therefore a marketing communication. This investment research has not been prepared in accordance with legal requirements designed to promote its independence and it is not subject to the prohibition on dealing ahead of the dissemination of investment research. This research does not constitute a personal recommendation or offer to enter into a transaction or an investment, and is produced and distributed for information purposes only.
Accendo Markets considers opinions and information contained within the research to be valid when published, and gives no warranty as to the investments referred to in this material. The income from the investments referred to may go down as well as up, and investors may realise losses on investments. The past performance of a particular investment is not necessarily a guide to its future performance. Prepared by Michael van Dulken, Head of Research